High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

BACKGROUND: Breast cancer anti-estrogen resistance 1 (BCAR1/p130cas) is a hub for diverse oncogenic signaling cascades and promotes tumor development and progression. METHODS: To understand the effect of BCAR1 in prostate cancer, we analyzed its expression on more than 11,000 prostate cancer samples...

Descripción completa

Detalles Bibliográficos
Autores principales: Heumann, Asmus, Heinemann, Nina, Hube-Magg, Claudia, Lang, Dagmar S., Grupp, Katharina, Kluth, Martina, Minner, Sarah, Möller-Koop, Christina, Graefen, Markus, Heinzer, Hans, Tsourlakis, Maria Christina, Wilczak, Waldemar, Wittmer, Corinna, Jacobsen, Frank, Huland, Hartwig, Simon, Ronald, Schlomm, Thorsten, Sauter, Guido, Steurer, Stefan, Lebok, Patrick, Hinsch, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756403/
https://www.ncbi.nlm.nih.gov/pubmed/29304771
http://dx.doi.org/10.1186/s12885-017-3956-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756403/
https://www.ncbi.nlm.nih.gov/pubmed/29304771
http://dx.doi.org/10.1186/s12885-017-3956-3

Ejemplares similares